QMED — QMed Share Price
Last trade - 00:00- $0.00m
- -$0.33m
- $5.25m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -166.51% | ||
| Return on Equity | -70.78% | ||
| Operating Margin | -169.04% | ||
Financial Summary
| Year End 30th Nov | Unit | 2003 | 2004 | 2005 | 2006 | 2007 | 2008E | 2009E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 12.65 | 15.34 | 21.96 | 8.14 | 5.25 | n/a | n/a | -16.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
QMed, Inc. (QMed) is a technology formulated and interactive disease management company that synchronizes scientific evidence to insure that the right care is received by patients. The services of QMed include Online Health Management System for Cardiovascular Disease (ohms/cvd), which is an integrated cardiovascular disease management system. ohms/cvd includes related systems to assist health plans and government organizations in managing the care, and cost of diabetes, cardiovascular conditions, including coronary artery disease (CAD), stroke, heart failure (CHF), hypertension, hyperlipidemia and the cardiovascular complications of diabetes. On November 2007, the Company ceased operations of its Managed Care Special Needs Plans and related services. On October 2007, it also sold its medical equipment business to an unaffiliated third party.
Directors
- Jane Murray CEO (50)
- William Schmitt CFO (52)
- Glenn Alexander VFN (46)
- A. Bruce Campbell DRC (62)
- Richard Levin DRC (63)
- Last Annual
- November 30th, 2007
- Last Interim
- February 29th, 2008
- Incorporated
- March 31st, 1987
- Public Since
- December 2nd, 1983
- No. of Shareholders
- 260
- No. of Employees
- 28
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 17,081,668
- Address
- 25 Christopher Way, EATONTOWN, 07724-3325
- Web
- Phone
- +1 7325445544
- Auditors
- Amper- Politziner & Mattia
Similar to QMED
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 22:48 UTC, shares in QMed are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in QMed last closed at $0.00 and the price had moved by +9900% over the past 365 days. In terms of relative price strength the QMed share price has outperformed the S&P500 Index by +9242.66% over the past year.
There is no consensus recommendation for this security.
Find out moreQMed does not currently pay a dividend.
QMed does not currently pay a dividend.
QMed does not currently pay a dividend.
To buy shares in QMed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in QMed had a market capitalisation of $0.00m.
Here are the trading details for QMed:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: QMED
Based on an overall assessment of its quality, value and momentum QMed is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like QMed. Over the past six months, its share price has outperformed the S&P500 Index by +10251.48%.
As of the last closing price of $0.00, shares in QMed were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The QMed PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
QMed's management team is headed by:
- Jane Murray - CEO
- William Schmitt - CFO
- Glenn Alexander - VFN
- A. Bruce Campbell - DRC
- Richard Levin - DRC